Mad in America

JANUARY 4, 2025

American psychiatry has weathered the crisis; it will not have to confront a public stunned by news of how the oft-cited 67% cumulative remission rate, in the largest and longest study ever done to evaluate depression treatment,” was born of scientific misconduct. Short of this, the best remaining course to take is a retraction.”

Pharmaceuticals 145

Pharmaceuticals Neurotransmitters and mental health Sleep and mental health Aging and mental health 145

Mad in America

JANUARY 3, 2024

“By making these materials on depressive illness available, accessible in physicians’ offices all over the country, important information is effectively reaching the public in settings which encourage questions, discussion, treatment, or referral,” said NIMH director Lewis Judd. psychiatrists.

Neurotransmitters and mental health 145

Neurotransmitters and mental health Hospitality Education Self-awareness 145

Mad in America

NOVEMBER 6, 2023

667 In an NIMH study of 547 patients that compared six-year outcomes for depressed people treated for the disorder and those who eschewed medical treatment, the treated patients were three times more likely than untreated ones to suffer a cessation of their principal social role and nearly seven times more likely to become incapacitated.

Bipolar disorder 145

Bipolar disorder Neurotransmitters and mental health Genetics and mental health Pharmaceuticals 145